Gilead Sciences Inc (NASDAQ:GILD)

74.85
Delayed Data
As of Sep 25
 -0.18 / -0.24%
Today’s Change
61.45
Today|||52-Week Range
89.74
-12.81%
Year-to-Date
AstraZeneca's (AZN) Dato-DXd Meets Goal in Breast Cancer Study
Sep 25 / Zacks.com - Paid Partner Content
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
Sep 18 / Zacks.com - Paid Partner Content
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Sep 21 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: MRNAs Pipeline News, RCKT, BCYC Rally on Study Updates
Sep 14 / Zacks.com - Paid Partner Content
Gilead's (GILD) Veklury Gets CHMP Nod in Damaged Liver Patients
Sep 20 / Zacks.com - Paid Partner Content
Gilead Sciences (GILD) Stock Moves -0.31%: What You Should Know
Sep 12 / Zacks.com - Paid Partner Content
Should You Invest in the iShares Biotechnology ETF (IBB)?
Sep 20 / Zacks.com - Paid Partner Content
Time for Gilead Sciences-Heavy ETFs?
Sep 12 / Zacks.com - Paid Partner Content
1 Huge Risk That Gene-Editing Stock Investors Desperately Need to Know
Sep 19 / MotleyFool.com - Paid Partner Content